Home Healthcare IT Europe Neurodegenerative Disease Market Growth, Latest Trend Analysis and Forecast 2030

Europe Neurodegenerative Disease Market

Europe Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Other Drug Types) and By Country(U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, Rest of Europ) Forecasts, 2022-2030

Report Code: SRHI3166DR
Study Period 2018-2030 CAGR 3.85%
Historical Period 2018-2020 Forecast Period 2022-2030
Base Year 2021 Base Year Market Size USD XX Billion
Forecast Year 2030 Forecast Year Market Size USD 53275 Million
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  • Europe Neurodegenerative Disease Market, By Indication Type (2020-2030)
    1. Parkinson's Disease
    2. Alzheimer's Disease
    3. Multiple Sclerosis
    4. Huntington Disease
    5. Other Indication Types
  • Europe Neurodegenerative Disease Market, By Drug Type (2020-2030)
    1. N-methyl-D-aspartate Receptor antagonists
    2. Cholinesterase Inhibitors
    3. Dopamine Agonists
    4. Immunomodulatory Drugs
    5. Other Drug Types

    Related Reports

    Global Report
    The global regenerative medicine market size was valued at USD 13.4 Billion in 2022. It is expected to reach USD 72.2 Billion by 2031, growing at a CAGR of 17.6% during the forecast period (2023–2031). Regenerative medications are us
    Buy Now

    Purchase Benefits

    • Eligible for a free updated report next year
    • Completely customizable scope
    • 30% discount on your next purchase
    • Dedicated account manager
    • Query resolution within 24 hours
    • Permission to print the report

    We are featured on :